Clinical trial RIBOB
A phase IV Study to collect data on the efficacy and safety of RIBociclib in combination with letrozole in Older women (?70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced Breast cancer (aBC) with no prior systemic therapy for advanced disease
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 4 |
| Academic trial | Oui |
| Sponsor | UZ-K.U.Leuven |
| BECT Identifier | B322201838186 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03956654 |
| Last update |